Back to Search Start Over

172P A multi-center, randomized, double-blind, parallel, two-group phase III clinical study on the efficacy and safety of QL1101 or bevacizumab in combination with paclitaxel and carboplatin in the first-line treatment of non-squamous non-small cell lung cancer

Authors :
Han, B
Li, K
Chu, T
Bi, M
Zhang, H
Yu, Y
Shi, J
Zhang, X
Chen, Z
Han, C
Bai, T
Source :
Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.
Publication Year :
2019

Subjects

Subjects :
*BEVACIZUMAB
*CARBOPLATIN

Details

Language :
English
ISSN :
09237534
Volume :
30
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
136076544
Full Text :
https://doi.org/10.1093/annonc/mdz063.070
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details